Dr Ronald Castelino

Experts / Dr Ronald Castelino

Dr Ronald Castelino

Practising Renal Pharmacist; Senior Lecturer, University of Sydney, Faculty of Medicine and Health, School of Pharmacy

Dr Ronald Castelino is a Senior Lecturer at the University of Sydney, Faculty of Medicine and Health, School of Pharmacy. He is a practising renal pharmacist (Blacktown Hospital) with a track record in translational research relevant to renal medicine. He is also interested in health services research that focusses on developing interventions to improve medication safety and quality use of medicines.

DOAC dosing in special situations – Renal impairment, liver disease and obesity

Inappropriate DOAC dosing is a common problem- recognise which patients require reduced dosage, what GPs can do to optimise the dosage in view of the specific clinical characteristics of each patient.

DOAC dosing in special situations – Renal impairment, liver disease and obesity

Inappropriate DOAC dosing is a common problem- recognise which patients require reduced dosage, what GPs can do to optimise the dosage in view of the specific clinical characteristics of each patient.

By Dr Ronald Castelino

Podcasts

Renal medicine

Dr Ronald Castelino

Practising Renal Pharmacist; Senior Lecturer, University of Sydney, Faculty of Medicine and Health, School of Pharmacy

More from this expert

DOAC dosing in special situations – Renal impairment, liver disease and obesity

Inappropriate DOAC dosing is a common problem- recognise which patients require reduced dosage, what GPs can do to optimise the dosage in view of the specific clinical characteristics of each patient.

DOAC dosing in special situations – Renal impairment, liver disease and obesity

Inappropriate DOAC dosing is a common problem- recognise which patients require reduced dosage, what GPs can do to optimise the dosage in view of the specific clinical characteristics of each patient.

Get the app

Site

Company

Connect

Legal

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.

Dr Ronald Castelino

Practising Renal Pharmacist; Senior Lecturer, University of Sydney, Faculty of Medicine and Health, School of Pharmacy

More from this expert

DOAC dosing in special situations – Renal impairment, liver disease and obesity

Inappropriate DOAC dosing is a common problem- recognise which patients require reduced dosage, what GPs can do to optimise the dosage in view of the specific clinical characteristics of each patient.

DOAC dosing in special situations – Renal impairment, liver disease and obesity

Inappropriate DOAC dosing is a common problem- recognise which patients require reduced dosage, what GPs can do to optimise the dosage in view of the specific clinical characteristics of each patient.

Save time on registrations, track CPD, listen to full podcasts... sign in to your Healthed account now

Don't have an existing account? Sign up today

Sign up for a free Healthed account

Extra Details

PASSWORD RESET

Discover

Healthed

Upcoming Healthed Webcast

New Brain Health Guidelines – What GPs Can Do

Tuesday 4th August, 7pm - 9pm AEST

Speaker

Scientia Prof Kaarin Anstey

Psychologist; Director, UNSW Ageing Futures Institute; ARC Laureate Fellow; Senior Principal Research Scientist, NeuRA

Scientia Prof Kaarin Anstey translates the WHO's updated 2026 dementia risk-reduction guidelines changes into concrete actions for opportunistic risk assessment and targeted advice in everyday general practice.